Los Angeles Capital Management LLC Raises Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Los Angeles Capital Management LLC lifted its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 92.3% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 55,597 shares of the company’s stock after purchasing an additional 26,690 shares during the period. Los Angeles Capital Management LLC’s holdings in HealthEquity were worth $4,551,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. International Assets Investment Management LLC acquired a new stake in HealthEquity during the 2nd quarter valued at $35,000. Paladin Wealth LLC purchased a new position in shares of HealthEquity in the 3rd quarter worth $39,000. GAMMA Investing LLC raised its position in shares of HealthEquity by 114.8% in the 2nd quarter. GAMMA Investing LLC now owns 595 shares of the company’s stock worth $51,000 after buying an additional 318 shares during the period. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of HealthEquity in the 2nd quarter worth $73,000. Finally, 1620 Investment Advisors Inc. purchased a new position in HealthEquity in the third quarter valued at about $112,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

Insider Activity

In other HealthEquity news, Director Frank Corvino sold 1,039 shares of the business’s stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total transaction of $99,847.90. Following the sale, the director now directly owns 3,784 shares of the company’s stock, valued at $363,642.40. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other news, Director Robert W. Selander sold 8,250 shares of the company’s stock in a transaction on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total value of $684,585.00. Following the transaction, the director now directly owns 54,719 shares of the company’s stock, valued at approximately $4,540,582.62. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Frank Corvino sold 1,039 shares of the company’s stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total transaction of $99,847.90. Following the completion of the transaction, the director now directly owns 3,784 shares in the company, valued at $363,642.40. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 10,536 shares of company stock worth $884,517. Insiders own 2.20% of the company’s stock.

HealthEquity Stock Performance

HQY opened at $100.27 on Tuesday. The company has a market capitalization of $8.76 billion, a price-to-earnings ratio of 83.56, a price-to-earnings-growth ratio of 1.55 and a beta of 0.52. The company has a debt-to-equity ratio of 0.51, a current ratio of 4.10 and a quick ratio of 4.10. HealthEquity, Inc. has a 1-year low of $62.10 and a 1-year high of $100.97. The business has a 50 day moving average price of $83.57 and a two-hundred day moving average price of $80.60.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Tuesday, September 3rd. The company reported $0.66 EPS for the quarter, beating analysts’ consensus estimates of $0.50 by $0.16. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. The company had revenue of $299.93 million during the quarter, compared to the consensus estimate of $284.48 million. Research analysts predict that HealthEquity, Inc. will post 2.27 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have commented on HQY shares. JMP Securities reissued a “market outperform” rating and issued a $105.00 price objective on shares of HealthEquity in a research report on Wednesday, September 4th. Royal Bank of Canada reiterated an “outperform” rating and issued a $92.00 price target on shares of HealthEquity in a research note on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft boosted their price objective on HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. Bank of America lowered their target price on HealthEquity from $105.00 to $100.00 and set a “buy” rating for the company in a report on Wednesday, September 4th. Finally, Barrington Research reaffirmed an “outperform” rating and set a $105.00 target price on shares of HealthEquity in a report on Friday, September 20th. Twelve research analysts have rated the stock with a buy rating, Based on data from MarketBeat, HealthEquity has a consensus rating of “Buy” and a consensus target price of $103.83.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.